Ya Sham PA
Ya Sham PA was paid $608K by Medicaid between Jan 2018 and Nov 2024, across 25 billing codes. Its largest line is J0129, Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) — 94% of everything it billed.
SAN ANTONIO, TX 78240
Next to other Specialist providers in Texas
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,736 | $63K | |
| 2019 | 3,326 | $132K | |
| 2020 | 2,162 | $77K | |
| 2021 | 2,235 | $151K | |
| 2022 | 1,275 | $102K | |
| 2023 | 1,059 | $81K | |
| 2024incomplete | 242 | $2K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 94% | 896 | 800 | $572K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.7% | 1,872 | 1,860 | $23K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,129 | 1,038 | $5K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 723 | 703 | $3K |
| 20611 | <1% | 485 | 261 | $3K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 777 | 756 | $2K |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 120 | 116 | $203.53 |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 89 | 87 | $153.11 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,065 | 962 | $79.40 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 158 | 155 | $71.05 |
| 20610 | <1% | 31 | 12 | $65.70 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 15 | 15 | $61.50 |
13 more codes
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 13 | $18.58 |
| G8950 | Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented | 0% | 629 | $0.00 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 960 | $0.00 |
| 1006F | 0% | 242 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 188 | $0.00 |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 0% | 15 | $0.00 |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | 0% | 588 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 1,497 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 660 | $0.00 |
| G8783 | Normal blood pressure reading documented, follow-up not required | 0% | 207 | $0.00 |
| 1100F | 0% | 63 | $0.00 | |
| 3288F | 0% | 597 | $0.00 | |
| G8731 | Pain assessment using a standardized tool is documented as negative, no follow-up plan required | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Orange View Healthcare INC | Santa Ana, CA | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.